GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Immunovia AB (OSTO:IMMNOV) » Definitions » Price-to-Operating-Cash-Flow

Immunovia AB (OSTO:IMMNOV) Price-to-Operating-Cash-Flow : (As of May. 19, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Immunovia AB Price-to-Operating-Cash-Flow?

As of today (2024-05-19), Immunovia AB's share price is kr1.452. Immunovia AB's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was kr-3.02. Hence, Immunovia AB's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Immunovia AB's Price-to-Operating-Cash-Flow or its related term are showing as below:

OSTO:IMMNOV's Price-to-Operating-Cash-Flow is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 18.41
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Immunovia AB's Cash Flow from Operations per share for the three months ended in Mar. 2024 was kr-0.54. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was kr-3.02.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 12.60% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -2.20% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was -50.20% per year.

During the past 11 years, Immunovia AB's highest 3-Year average Operating Cash Flow per Share Growth Rate was 12.60% per year. The lowest was -181.40% per year. And the median was -41.95% per year.


Immunovia AB Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Immunovia AB's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immunovia AB Price-to-Operating-Cash-Flow Chart

Immunovia AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Immunovia AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Immunovia AB's Price-to-Operating-Cash-Flow

For the Diagnostics & Research subindustry, Immunovia AB's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Immunovia AB's Price-to-Operating-Cash-Flow Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Immunovia AB's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Immunovia AB's Price-to-Operating-Cash-Flow falls into.



Immunovia AB Price-to-Operating-Cash-Flow Calculation

Immunovia AB's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=1.452/-3.023
=

Immunovia AB's Share Price of today is kr1.452.
Immunovia AB's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-3.02.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Immunovia AB Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Immunovia AB's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Immunovia AB (OSTO:IMMNOV) Business Description

Traded in Other Exchanges
Address
Medicon Village, Scheelevagen 8, Lund, SWE, 223 63
Immunovia AB molecular diagnostic company. It develops and commercializes diagnostic tools for complex forms of cancer and autoimmune diseases. Its technology platform IMMray (TM), is based on antibody microarray analysis. The group's intangible and tangible assets are in Sweden, in the United States and in Germany.

Immunovia AB (OSTO:IMMNOV) Headlines

No Headlines